https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1364161/full
Frontiers | Corilagin alleviates atherosclerosis by inhibiting NLRP3 inflammasome activation via...
Atherosclerosis, a leading cause of global cardiovascular mortality, is characterized by chronic inflammation. Central to this process is the NOD-like recept...
nlrp3 inflammasomefrontierscorilaginatherosclerosisinhibiting